Study of nirgundi and hadjod base formulation on knee joint ostioarthritis
Phase 2
Not yet recruiting
- Conditions
- Osteoarthritis of knee, unspecified,
- Registration Number
- CTRI/2022/07/043798
- Lead Sponsor
- CSIR NEW DELHI HCP
- Brief Summary
A CLINICAL STUDY TO EVALUTE THE EFFICACY OF NIRGUNDI AND HADJOD BASE ORAL AND TROPICAL FORMULATION ON KNEE JOINT OF OSTIOARTHRITIS PATIENTS WILL BE DONE ON 60 PATIENTS AS PER OUR INCLUSION AND EXCLUSION CRITERIA ON THE DURATION OF 6 MONTH. AFTER COMPLETION OF TRIAL THE OUTCOME WILL ANALYZED AS PER SUBJECTIVE AND OBJECTIVE PARAMETER.AFTER C.OMPLETION OF THE STUDY WE WILL PUBLISE THE STUDY ON REPUTATE JOURNAL.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Volunteers with affected joints,who are willing to undergo the treatment.
- Age between 40 -70 years.
- Individuals who are willing and able to participate for 6 months of duration.
Exclusion Criteria
- Patients not willing for trial.
- Patients below the age of 40 years and above 70 years.
- Patients who have participated in any clinical trial during past 6 months.
- Subjects with cardiac problems.
- Subjects with uncontrolled diabetes mellitus Subjects with multiple joint disorders.
- Subjects with advanced rheumatoid arthritis.
- Subject advanced knee osteoarthritis.
- Subjects suffering from major systemic illness necessitating long term drug treatment (R.A, PTB, malignancy etc.) Any other condition which the Investigator thinks may compromise the safety of the subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement will be evaluated by objective evaluation of knee joints (affected joint or both joints) (mandatory); X-ray and MRI depending upon availability. It will be done to check the efficacy of the productOSTEOARTHRITIS PATIENT. 8 WEEKS EFFECT ON CHOLEGEN HEALTH 8 WEEKS
- Secondary Outcome Measures
Name Time Method Other parameters such as Complete Blood Count, ESR, Liver function test, renal function test etc will be evaluated to check safety and any adverse effect on the patient. 8 WEEKS
Trial Locations
- Locations (1)
OPD NO 213 Surgery Department
🇮🇳Kangra, HIMACHAL PRADESH, India
OPD NO 213 Surgery Department🇮🇳Kangra, HIMACHAL PRADESH, IndiaDR ANIL KUMAR SHARMAPrincipal investigator9805056393dranilpaprola@gmail.com